Soft tissue sarcoma therapy: prospects for future studies.
Lejeune
F J
FJ
Pluridisciplinary Oncology Center, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Liénard
D
D
Rüegg
C
C
Leyvraz
S
S
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009389:Neovascularization, Pathologic; D010477:Perfusion; D012509:Sarcoma / Q000188:drug therapy / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage
D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha